Cancer chemotherapy associated symptomatic stomatitis. Role of herpes simplex virus (HSV)

Cancer

Volumn 50, Issue 7, 1982, Pages 1262-1265

  Rand, Kenneth H ^a   Kramer, Barnett ^a   Johnson, Alicia C ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSTATIC AGENT;

ADVERSE DRUG REACTION; CANCER CHEMOTHERAPY; ETIOLOGY; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; IMMUNOSUPPRESSIVE TREATMENT; MOUTH; MOUTH HYGIENE; PATHOGENESIS; STOMATITIS; THERAPY; VIRUS ISOLATION;

ANTIBODIES, VIRAL; ANTINEOPLASTIC AGENTS; HUMAN; MOUTH; PROBABILITY; PROSPECTIVE STUDIES; SIMPLEXVIRUS; STOMATITIS, HERPETIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0019952490     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19821001)50:7<1262::AID-CNCR2820500707>3.0.CO;2-F     Document Type: Article

References (9)

1. The variability of individual tolerance to methotrexate in cancer patients
2. Identification of patients with increased risk of infection with Herpes simplex virus after renal transplantation
3. Cellular immunity and Herpes virus infections in cardiac‐transplant patients
4. Infection with Herpes simplex virus and cell‐mediated immunity after marrow transplant
5. Herpes simplex infections in hematologic malignancies
6. Herpesvirus hominis infection in patients with myeloproliferative and lymphoproliferative disorders
7. Herpes simplex infection in Acute Myelogenous Leukemia and Other Hematological Malignancies: A Prospective Study
8. A prospective study of chronic Herpes simplex virus infection and recurrent Herpes labialis in humans
9. Controlled clinical trial of intravenous acyclovir in heart‐transplant patients with mucocutaneous herpes simplex infections